STATISTICS04 Home
  • EN

Table TDI-10. Characteristics of all clients treated for drug problems: demographics and primary drug at treatment in 2002 or most recent year available. Part (ii) Main drug (percentage) and of those the percent injecting it (italics)

Country   Opiates % inj Cocaine % inj Amphet amines % inj Ecstasy Hallucin ogens % inj Cannabis Others
                           
Belgium (1) 33.2 37.7 6 11 12 6 1 0 0 15 32.8  
Czech Republic (2) 25.5 84.1 0.1 15.4 49.7 85 2.4 0.5 4.3 16.1 0.6  
Denmark (3) 46 43 3 15 5 10 1 0 0 27 18  
Germany (4) 51 na 6 na 7 na na 0 na 30 6  
Greece   88.9 59.2 1.3 18.2 0 0 0.4 0.1 0 7.3 2  
Spain   59 24 26 9 1 9 1 0.1 14 11 3  
France (5) 69.6 19 4.9 15 0.3 10 0.7 0.4 8 13.5 10.6  
Ireland (6) 67.9 99.7 1.2 0.1 0.6 0.1 5.9 0.2 0 21.4 2.8  
Italy (7) 80.6 68.9 7 17 0.2 1 0.8 0.1 na 9.1 2.2  
Latvia (8) 81.1 95.3 0.2 0 1.6 na 0 0.3 0 1.7 15.1  
Lithuania (9) 79.4 na 0.1 na 2.3 na na 0.2 na 0.6 17.4  
Luxembourg   80 69 6 56 0 0 0 0 0 11 3  
Hungary (11) 22 66 1 13 3 22 2 1 7 14 57  
Netherlands (12) 42 13 35 2 2 3 1 0 0 17 3  
Austria (13) 100 100 0 0 0 0 0 0 0 0 0  
Portugal (14) na na na na na na na na na na na  
Slovenia   90.4 99.4 0.6 0.4 0.1 0 0.4 0.1 0 7.6 0.8  
Slovakia   65 79.4 0.6 0 9.1 47.4 0.4 0.4 0 10.5 14  
Finland   34.1 88 0.2 na 34 79 0.6 0.1 na 22.9 8.2  
Sweden (15) 24 32 2 0 27 31 2 0 0 30 15  
United Kingdom (16) 75 54 6 10 3 39 1 0.1 6 10 4.9  
                           
Notes:  
    Data were not available for: Estonia, Cyprus, Malta, Poland and Norway.  
    Injecting as a route of administration is not reported for cannabis.  
Belgium (1) Data refer only to outpatient treatment centres. Last data available refer to 1999.  
Czech Republic (2) Data refer to all treatment centres.  
Denmark (3) Injecting use for opiates refers only to heroin, and cocaine only to cocaine CIH. For distribution by main drug only clients attending outpatient centres.  
Germany (4) Data only refer to outpatient treatment centres; information about injecting use is not available. Amphetamines also include ecstasy.  
France (5) The last available data on treatment demand are reported, referring to the annual census on clients in treatment carried out in November 1999.  
Ireland (6) Last data available refer to 2000.  
Italy (7) Data only refer to outpatient treatment centres; information about injecting opiate use refers only to heroin, for cocaine only to cocaine CIH.  
Latvia (8) Data refer only to outpatient treatment centres.  
Lithuania (9) Amphetamines include all stimulants.  
Hungary (11) 39% of clients are reported to use hypnotics/sedatives, 18% other substances.  
Netherlands (12) Data refer only to outpatient treatment centres.  
Austria (13) Data refer to clients in substitution treatment only; figures for opiates as main drug and injecting use are consequently 100%.
Portugal (14) Coverage is limited and variable, with no control on double counting of clients.  
Sweden (15) Data refer only to outpatient treatment centres.  
United Kingdom (16) Data relate to the period from 1 April 2001 to 31 March 2002 for Scotland and Northern Ireland; for England and Wales six months data ending 30 September 2000 plus six months data ending 31 March 2001.  
                           
Sources: 2003 Reitox national reports, Standard table 3, see [Table TDI-10 Part (iii)] for details on sources.
       

Download
Download this attachment in XLS format

Print

Page last updated: Monday, 22 November 2004